Another possible reason relates to clinical interest being driven by marketing forces, which means that pharmaceutical paradigms might predominate. There is little commercial benefit to be obtained from promoting moderate physical activity, so private sector sponsors are unlikely to materialise. This may drive editorial policy in this area, and appears to do so internationally. Our data suggest the need for physical activity advocacy, not only by public health personnel, but also by journal editors and senior clinicians. There is a need to reposition physical activity commensurate with its importance as a risk factor for heart disease and diabetes, and as an evidence-based preventive approach for many other conditions.
Medical practice is a central setting for physical activity advice.
This means that the medical media in general, and clinical specialists in disciplines including cardiology, endocrinology, injury prevention and mental health, need to be more vigilant in recommending moderate activity, and encourage all doctors to advise their patients accordingly. This could lead to patients' becoming generally more active, and, by achieving recommended levels of activity, contributing to health gains for all Australians. The authors were the recipients of a 1997 grant from the University of New South Wales School of Community Medicine Small Grants Scheme. References United States Department of Health and Human Services. Actual causes of death in the United States.